Interestingly, after controlling for EBV-VCA-IgA status, the genotypes GG, AG, and GG + AG emerged as conferring higher risk of NPC, with respective ORs of 2.976 (95%CI 1.123–7.888), 3.314 (95%CI 1.274–8.622), and 3.191 (95%CI 1.237–8.230) (Table 5). This evidence concerns the gene CD79A and nasopharyngeal carcinoma.